The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer

NCT06446401 · clinicaltrials.gov ↗

RECRUITING

Status

1400

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: ADT + NHT + Docetaxel
DRUG: ADT + NHT

Sponsor

Uppsala University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]